Want to track BCAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bicara Therapeutics Inc. (BCAX) Statistics
Valuation metrics
Market Cap 1.54B
Enterprise value 1.2B
Trailing P/E (ttm) -9.99
Forward P/E -
PEG ratio 0.22
Price/Sales (ttm) -
Price/Book (mrq) 3.28
Enterprise Value/Revenue -
Enterprise Value/EBITDA -7.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 455.79K
Average volume (90 days) 553.27K
Price summary
52-Week low 9.57
52-Week high 30.99
Beta -
50-Day moving average 25.49
200-Day moving average 19.52
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.28%
Return on equity -0.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.89
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 13.85%
Book value per share (mrq) 8.46
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
